The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy
Dana V. Rizk(University of Alabama at Birmingham), Robert Wyatt(Seattle Children's Hospital)
Cited by 166
Related Papers
Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN Study
|Kidney International Reports|2023|59